• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA clears ATL's Access system

Article

The Food and Drug Administrationthis month gave ultrasound vendor ATL the thumbs-up to sell itsAccess ultrasound image management system. ATL plans to beginshipping Access this fall, according to Lance Hood, manager ofAccess operations. Access was

The Food and Drug Administrationthis month gave ultrasound vendor ATL the thumbs-up to sell itsAccess ultrasound image management system. ATL plans to beginshipping Access this fall, according to Lance Hood, manager ofAccess operations.

Access was developed by ATL's Nova MicroSonics division andworks with both ATL systems and those of other vendors. The systemwas initially known as Digital Laboratory until ATL changed theproduct's name to Access at last year's Radiological Society ofNorth America meeting (SCAN 12/29/93).

There are three main elements to Access:

** A 486 66-MHz workstation running IBM's OS/2 operating system.ATL offers the Access workstation in two options: Access 200,a desktop configuration, and Access 300, a tower configuration.In addition, Access 300 can be placed on a cart for mobile operations;

** An acquisition module that acquires the video output ofultrasound systems. The module can either digitize the signalinto an ACR-NEMA DICOM 3.0 signal for networking or store it ontoan optical disk in the data exchange file format (DEFF) protocol;and

** A 486-based network file server that archives and retrievesnetworked ultrasound images. As an option, the server can be linkedto an optical disk jukebox that can store up to 144 platters.

Access is scalable, with options ranging from a single Accessacquisition module to multiple workstations networked to an opticaldisk jukebox. An Access system for a typical ultrasound departmentwill cost between $75,000 to $150,000, according to Hood.

In other ATL news, the company announced that it has openeda subsidiary in Singapore for sales and service of ultrasoundequipment throughout Asia. ATL Singapore Ltd. will support ATL'sgrowing customer base in the region, the company said.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.